We are live on !
Find out more
Fairman Group Portfolio holdings
AUM
$140M
Turnover
7.54%
1-Year Est. Return
10.49%
This Fund
S&P 500
This Quarter Est. Return
+6.41%
1 Year Est. Return
+10.49%
3 Year Est. Return
+46.82%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$140M
AUM Growth
+$12.4M
(+9.8%)
Cap. Flow
+$6.57M
Cap. Flow % of AUM
Cap. Flow %
4.7%
Top 10 Holdings %
Top 10 Hldgs %
66.24%
Holding
345
New
13
Increased
74
Reduced
17
Closed
13
Avg Time Held
1.9
years
Top 10 Avg Time Held
1.9
years
Top 20 Avg Time Held
2.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Russell 1000 Value ETF
VONV
|
+$1.95M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$1.81M |
| 3 |
TCW Transform 500 ETF
VOTE
|
+$1.65M |
| 4 |
Strive 500 ETF
STXF
|
+$972K |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$654K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Diamond Hill Large Cap Concentrated ETF
DHLX
|
+$1.18M |
| 2 |
Vanguard Morningstar Large-Cap ETF
VV
|
+$1.09M |
| 3 |
Accenture
ACN
|
+$292K |
| 4 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$131K |
| 5 |
Vanguard Total World Stock ETF
VT
|
+$97.5K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 73.65% |
| 2 | Technology | 13.24% |
| 3 | Financials | 7.6% |
| 4 | Healthcare | 1.46% |
| 5 | Consumer Discretionary | 1.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
301
Strategy Inc
MSTR
$60.4B
| $919 | ﹤0.01% |
+6
| New | +$694 |
2026 Q3
0 quarters
|
|
302
Medtronic
MDT
$134B
| $870 | ﹤0.01% |
10
| – | – |
2023 Q4
11 quarters
|
|
303
Virtus Investment Partners
VRTS
$854M
| $794 | ﹤0.01% |
6
| – | – |
2023 Q4
11 quarters
|
|
304
Solstice Advanced Materials
SOLS
$9.17B
| $732 | ﹤0.01% |
13
+11
| +550% | +$667 |
2025 Q4
3 quarters
|
|
305
Baxter International
BAX
$13.7B
| $720 | ﹤0.01% |
30
| – | – |
2023 Q4
11 quarters
|
|
306
BBVA Argentina
BBAR
$2.28B
| $694 | ﹤0.01% |
+54
| New | +$899 |
2026 Q3
0 quarters
|
|
307
Diageo
DEO
$54.3B
| $685 | ﹤0.01% |
8
| – | – |
2023 Q4
11 quarters
|
|
308
Biogen
BIIB
$37.6B
| $678 | ﹤0.01% |
3
| – | – |
2023 Q4
11 quarters
|
|
309
Unilever
UL
$144B
| $668 | ﹤0.01% |
11
| – | – |
2023 Q4
11 quarters
|
|
310
PPG Industries
PPG
$28.1B
| $626 | ﹤0.01% |
6
| – | – |
2023 Q4
11 quarters
|
|
311
Commerce Bancshares
CBSH
$7.98B
| $493 | ﹤0.01% |
9
| – | – |
2023 Q4
11 quarters
|
|
312
State Street Blackstone Senior Loan ETF
SRLN
$5.17B
| $485 | ﹤0.01% |
12
| – | – |
2026 Q1
2 quarters
|
|
313
Carrier Global
CARR
$45.5B
| $439 | ﹤0.01% |
8
| – | – |
2023 Q4
11 quarters
|
|
314
CVS Health
CVS
$102B
| $428 | ﹤0.01% |
5
| – | – |
2023 Q4
11 quarters
|
|
315
Molson Coors Class B
TAP
$8.04B
| $365 | ﹤0.01% |
10
| – | – |
2023 Q4
11 quarters
|
|
316
Ambev
ABEV
$42.5B
| $347 | ﹤0.01% |
117
| – | – |
2023 Q4
11 quarters
|
|
317
Otis Worldwide
OTIS
$30.4B
| $257 | ﹤0.01% |
4
| – | – |
2023 Q4
11 quarters
|
|
318
Haleon
HLN
$40.6B
| $225 | ﹤0.01% |
25
| – | – |
2023 Q4
11 quarters
|
|
319
Fulton Financial
FULT
$4.64B
| $203 | ﹤0.01% |
9
| – | – |
2024 Q1
10 quarters
|
|
320
Versant Media Group
VSNT
$4.73B
| $190 | ﹤0.01% |
6
| – | – |
2026 Q1
2 quarters
|
|
321
Immersion
IMMR
$238M
| $137 | ﹤0.01% |
19
| – | – |
2023 Q4
11 quarters
|
|
322
Garrett Motion
GTX
$3.65B
| $130 | ﹤0.01% |
5
+4
| +400% | +$116 |
2023 Q4
11 quarters
|
|
323
Jackson Financial
JXN
$9.3B
| $129 | ﹤0.01% |
1
| – | – |
2023 Q4
11 quarters
|
|
|
MBGL
324
Mobility Global Inc
MBGL
$6.33B
| $120 | ﹤0.01% |
+7
| New | +$141 |
2026 Q3
0 quarters
|
|
325
SEI Investments
SEIC
$12.9B
| $87 | ﹤0.01% |
1
| – | – |
2023 Q4
11 quarters
|
|
Similar funds
SAM
BIO
BCP
Fairman Group's Q3 2026 Portfolio in Review
As of Q3 2026, Fairman Group held 345 positions worth $140M, up 9.8% from $127M the previous quarter. Its ten largest holdings account for 66% of the portfolio.
Fairman Group deployed $6.57M of net new capital in Q3 2026, opening 13 new positions and adding to 74 existing holdings. Its largest new stake was Progressive: 47 shares worth $9.7K.
By sector, the portfolio is most concentrated in Miscellaneous at 74% of assets, down from 75% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Diamond Hill Large Cap Concentrated ETF, an estimated $1.18M trimmed.
- Fairman Group's largest Q3 2026 buy was Progressive: 47 shares worth $9.7K.
- Fairman Group added most to Vanguard Russell 1000 Value ETF in Q3 2026, an estimated $1.95M increase.
- Fairman Group's biggest Q3 2026 reduction was Diamond Hill Large Cap Concentrated ETF, cutting an estimated $1.18M.
- Fairman Group fully exited iShares Gold Trust Micro in Q3 2026, selling an estimated $38.4K.
- Fairman Group's ten largest holdings make up 66% of its $140M portfolio in Q3 2026.
- Fairman Group opened 13 new positions and closed 13 in Q3 2026.
- Fairman Group's portfolio value rose 9.8% quarter-over-quarter to $140M.
Based on Fairman Group's 13F filing for Q3 2026, filed 26 Oct 2026.